SB1847 Summary

• Establishes warning label requirements for medical marijuana packaging stating that marijuana use may affect pregnant women and unborn children, applicable to dispensaries and marijuana establishments.

• Creates a new marijuana research grant program funded by the medical marijuana fund to study the correlation between marijuana use and mental illness, including psychosis and violent behavior.

• Requires nonprofit medical marijuana dispensaries to test products for microbial contamination, heavy metals, pesticides, fungicides, growth regulators, and residual solvents, and provide test results to patients on request.

• Allocates $55 million from the medical marijuana fund for specific purposes including $15 million to the Arizona Teachers Academy, $10 million for public health programs, $10 million for impaired driving prevention, and funding for mental health services and research.

• Exempts the Department of Health Services from standard rulemaking requirements for 36 months to implement the act, while requiring public comment opportunities on proposed rules.